Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
240.34
-0.95 (-0.39%)
Dec 3, 2024, 12:15 PM EST - Market open
Danaher Revenue
Danaher had revenue of $5.80B in the quarter ending September 27, 2024, with 3.09% growth. This brings the company's revenue in the last twelve months to $23.74B, up 12.92% year-over-year. In the year 2023, Danaher had annual revenue of $23.89B, down -10.33%.
Revenue (ttm)
$23.74B
Revenue Growth
+12.92%
P/S Ratio
7.47
Revenue / Employee
$376,857
Employees
63,000
Market Cap
173.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 23.89B | -2.75B | -10.33% |
| Dec 31, 2022 | 26.64B | 1.84B | 7.42% |
| Dec 31, 2021 | 24.80B | 2.52B | 11.30% |
| Dec 31, 2020 | 22.28B | 4.37B | 24.42% |
| Dec 31, 2019 | 17.91B | 862.00M | 5.06% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pfizer | 59.38B |
| Sanofi | 54.03B |
| AstraZeneca | 51.21B |
| Novartis AG | 49.94B |
| Thermo Fisher | 42.37B |
| Abbott Laboratories | 41.22B |
| Amgen | 32.53B |
| Stryker | 21.97B |
DHR News
- 6 days ago - Danaher to Present at Evercore ISI HealthCONx Conference - PRNewsWire
- 18 days ago - Revving Up: 2 Underperforming Dividend Giants Ready To Outshine - Seeking Alpha
- 5 weeks ago - Understanding Danaher's Cautiousness - Seeking Alpha
- 5 weeks ago - Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating - Benzinga
- 6 weeks ago - Danaher Corporation (DHR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Danaher beats quarterly profit estimates on strong demand for bioprocessing unit - Reuters
- 6 weeks ago - Danaher Reports Third Quarter 2024 Results - PRNewsWire
- 2 months ago - 3 Dividend Titans With Pricing Power Straight From The Hedge Fund Playbook - Seeking Alpha